| |
Actual 2010 |
Target 2010 |
| Organic sales growth |
19%1
|
>5% per year on average |
| EBITDA / net sales margin per cluster |
|
|
| - Nutrition |
23.4% |
>18% |
| - Pharma |
8.8% |
>19% |
| - Performance Materials |
11.9% |
>17% |
| - Polymer Intermediates2
|
16.4% |
>13% |
| Growth from Innovation |
€ 1.3 billion |
€ 1 billion |
| Sales in China |
USD 1.6 billion |
USD 1.5 billion |
| CFROI4
|
9.2% |
WACC (7.5%) + 100 basis points |
| Sustainability |
all achieved |
|
| - Retaining top position in important sustainability rankings |
| - Achieving leadership in industrial (white) biotechnology |
| - Continuously improving eco-footprint |
| - Increasing the diversity of workforce |
| - Reducing energy usage per unit of product by 8% over the period 2005-2010 |
| Total shareholder return |
130% vs. 146% for peer group3
|
Above peer group average |
|
1
Average over the period 2006-2010: 5%
|
|
2
On average over the cycle 2006-2010: 9.2%
|
|
3
Total Shareholder Return 2006-2010 DSM: 131%, peer group: 151%. The peer group consists of AkzoNobel. BASF, Clariant, Danisco, DuPont, EMS Chemie Holding, Kerry, LANXESS, Lonza Group, Novozymes, Rhodia and Solvay.
|
|
4
Achieved in four out of five years during the Vision 2010 period.
|
